Skip to main content

Table 8 Recommendation summary - blood pressure management

From: Diagnosis and management of non-dialysis chronic kidney disease in ambulatory care: a systematic review of clinical practice guidelines

 

CEBAM

ACP

HAS

KDIGO

KHA-CARI

BCMA

UMHS

VA-DoD

NICE

2012

2013

2013

2013

2013

2014

2014

2014

2015

Blood pressure management

 BP monitoring intervals

     

    

 individualized BP targets

    

 

  

 BP target

< 140/90

 

 BP target in diabetics

< 140/90

      

GP

  
 

< 140/80

         
 

< 130/80

    

   

 BP target in ≥ microalbuminuria

< 140/90

      

  
 

< 130/80

   

 

i

 

 medication

renin-angiotensin system antagonist

     

i ➢

  

i

 

ACEI

i

i

 

i

i

i

i

 
 

ARB

 

i

 

i

i

i

i

 
 

combination of ACEI + ARB

   

  

 

combination of ACEI/ARB + direct renin inhibitor

    

 

 
 

diuretics

    

i

i

   
 

β-blocker

    

i

i

   
 

calcium channel blocker

    

i

i

   
 

side effects

        
  1. ▪ recommendation, − negative recommendation, i: when indicated, ➢ recommendations in KDIGO BP guideline, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, BP blood pressure, DM diabetes mellitus, ev insufficient evidence for recommendation, GP: identical blood pressure targets as general population, n.a.: not applicable
  2. American College of Physicians (ACP), Belgisch Centrum voor Evidence Based Medicine (CEBAM), British Columbia Medical Association (BCMA), Department of Veteran’s Affairs (VA-DoD), Haute Autorité de Santé (HAS), Kidney Disease Improving Global Outcomes (KDIGO), Kidney Health Australia - Caring for Australasiansians with Renal Impairment (KHA-CARI), National Institute of Health and Care Excellence (NICE), University of Michigan Health System (UMHS)